Clinical Trial Update: Open-Label, Extension Study to Evaluate the Safety of Hydrocodone Bitartrate Extended-Release Tablets [Phase 3]

View source ↗

Summary

Open-label extension study assessing long-term safety of hydrocodone bitartrate extended-release tablets for low back pain; completed with results posted in 201…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Low Back Pain

Drugs mentioned

• Hydrocodone Bitartrate Extended-Release Tablets (hydrocodone bitartrate)

Snippet

Sponsor: Teva Branded Pharmaceutical Products R&D, Inc. | Conditions: Low Back Pain | Phase 3 | Status: COMPLETED | Results posted: 2017-06-02